Emmanuel Papada

Stock Analyst

(n/a)

# 4,651

Out of 4,653 analysts

6

Total ratings

n/a

Success rate

n/a

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General

Stocks Rated by Emmanuel Papada

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	AZN AstraZeneca	Upgrades: Hold	n/a	$65.04	-	1	Apr 16, 2024
	SNY Sanofi	Upgrades: Equal-Weight	n/a	$47.82	-	2	Nov 1, 2018
	NVS Novartis AG	Upgrades: Equal-Weight	n/a	$103.40	-	3	Jul 19, 2018

AstraZeneca

Apr 16, 2024

Upgrades: Hold

Price Target: n/a

Current: $65.04

Upside: -

Sanofi

Nov 1, 2018

Upgrades: Equal-Weight

Price Target: n/a

Current: $47.82

Upside: -

Novartis AG

Jul 19, 2018

Upgrades: Equal-Weight

Price Target: n/a

Current: $103.40

Upside: -